| MeSH term | MeSH ID | Detail |
|---|---|---|
| Granuloma, Respiratory Tract | D015769 | 1 associated lipids |
| Staphylococcal Scalded Skin Syndrome | D013206 | 1 associated lipids |
| Stomatognathic Diseases | D009057 | 1 associated lipids |
| Moraxellaceae Infections | D045828 | 3 associated lipids |
| Tuberculosis, Multidrug-Resistant | D018088 | 6 associated lipids |
| Fecal Incontinence | D005242 | 1 associated lipids |
| Atrioventricular Block | D054537 | 1 associated lipids |
| Abdominal Abscess | D018784 | 2 associated lipids |
| Vagus Nerve Injuries | D061223 | 1 associated lipids |
| Pyloric Stenosis, Hypertrophic | D046248 | 2 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- J. Pharmacol. Exp. Ther. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Goodman LJ et al. | Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets. | 1986 | Antimicrob. Agents Chemother. | pmid:2940963 |
| Shore AC et al. | Identification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate. | 2010 | Antimicrob. Agents Chemother. | pmid:20921317 |
| Montanari MP et al. | Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. | 2003 | Antimicrob. Agents Chemother. | pmid:12821474 |
| Bingen E et al. | Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. | 2003 | Antimicrob. Agents Chemother. | pmid:12821495 |
| Wagner J et al. | Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. | 2003 | Antimicrob. Agents Chemother. | pmid:12821499 |
| Katz KC et al. | Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. | 2003 | Antimicrob. Agents Chemother. | pmid:12821502 |
| Hand WL and King-Thompson NL | Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. | 1986 | Antimicrob. Agents Chemother. | pmid:3790206 |
| Schultz MJ et al. | Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood. | 1998 | Antimicrob. Agents Chemother. | pmid:9660992 |
| Hand WL and Hand DL | Interactions of dirithromycin with human polymorphonuclear leukocytes. | 1993 | Antimicrob. Agents Chemother. | pmid:8109917 |
| Kadota J et al. | Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor. | 1998 | Antimicrob. Agents Chemother. | pmid:9661038 |
| Maurin M and Raoult D | In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. | 1993 | Antimicrob. Agents Chemother. | pmid:8109928 |
| Retsema J et al. | Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. | 1987 | Antimicrob. Agents Chemother. | pmid:2449865 |
| Dowling JN et al. | Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and Legionella pneumophila. | 1985 | Antimicrob. Agents Chemother. | pmid:3985605 |
| Vince R et al. | Binding of N-substituted erythromycyclamines to ribosomes. | 1976 | Antimicrob. Agents Chemother. | pmid:769668 |
| Waites KB et al. | In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. | 1988 | Antimicrob. Agents Chemother. | pmid:2973283 |
| Kasetty G et al. | The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection. | 2017 | Antimicrob. Agents Chemother. | pmid:28652240 |
| Wüst J and Hardegger U | Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile. | 1983 | Antimicrob. Agents Chemother. | pmid:6870225 |
| Desaki M et al. | Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. | 2004 | Antimicrob. Agents Chemother. | pmid:15105108 |
| Oster P et al. | Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. | 1999 | Antimicrob. Agents Chemother. | pmid:10508033 |
| Kaczmarek FS et al. | Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. | 2004 | Antimicrob. Agents Chemother. | pmid:15105114 |
| Kroboth PD et al. | Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects. | 1982 | Antimicrob. Agents Chemother. | pmid:7081971 |
| Unkles SE and Gemmell CG | Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. | 1982 | Antimicrob. Agents Chemother. | pmid:7081974 |
| McCormack WM et al. | Hepatotoxicity of erythromycin estolate during pregnancy. | 1977 | Antimicrob. Agents Chemother. | pmid:21610 |
| Cynamon MH and Klemens SP | Activity of azithromycin against Mycobacterium avium infection in beige mice. | 1992 | Antimicrob. Agents Chemother. | pmid:1329622 |
| Tamaoki J et al. | Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea. | 1994 | Antimicrob. Agents Chemother. | pmid:7979298 |
| Grinwis ME et al. | Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. | 2010 | Antimicrob. Agents Chemother. | pmid:20404127 |
| Sugie M et al. | Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. | 2004 | Antimicrob. Agents Chemother. | pmid:14982769 |
| Dixon JM and Lipinski AE | Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin. | 1972 | Antimicrob. Agents Chemother. | pmid:4598840 |
| Wayne LG and Walter H | Separation of erythromycin-resistant and -susceptible subpopulations of Escherichia coli 15 by partition in two-polymer aqueous phases. | 1974 | Antimicrob. Agents Chemother. | pmid:4599119 |
| Pestka S | Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics. | 1974 | Antimicrob. Agents Chemother. | pmid:4599122 |
| Finland M et al. | Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation. | 1974 | Antimicrob. Agents Chemother. | pmid:4599860 |
| Credito KL et al. | Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents. | 2001 | Antimicrob. Agents Chemother. | pmid:11120946 |
| Singh KV et al. | Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. | 2001 | Antimicrob. Agents Chemother. | pmid:11120975 |
| Palavecino EL et al. | Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. | 2001 | Antimicrob. Agents Chemother. | pmid:11120993 |
| Syrogiannopoulos GA et al. | Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. | 2001 | Antimicrob. Agents Chemother. | pmid:11120994 |
| Haas CE et al. | In vitro selection of resistant Helicobacter pylori. | 1990 | Antimicrob. Agents Chemother. | pmid:2285275 |
| Steidl R et al. | Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials. | 2008 | Antimicrob. Agents Chemother. | pmid:18541730 |
| Clermont D and Horaud T | Identification of chromosomal antibiotic resistance genes in Streptococcus anginosus ("S. milleri"). | 1990 | Antimicrob. Agents Chemother. | pmid:2285280 |
| Brandt-Rauf P et al. | Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes. | 1978 | Antimicrob. Agents Chemother. | pmid:356727 |
| Kohyama T et al. | Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. | 1999 | Antimicrob. Agents Chemother. | pmid:10103198 |
| Kohno Y et al. | Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. | 1989 | Antimicrob. Agents Chemother. | pmid:2526615 |
| Gorby GL and McGee ZA | Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells. | 1990 | Antimicrob. Agents Chemother. | pmid:1982402 |
| Besier S et al. | Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances. | 2008 | Antimicrob. Agents Chemother. | pmid:18212098 |
| Tsuda T et al. | Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. | 2008 | Antimicrob. Agents Chemother. | pmid:18212111 |
| Waites KB et al. | In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China. | 2017 | Antimicrob. Agents Chemother. | pmid:27855075 |
| Pestka S and Lemahieu RA | Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes. | 1974 | Antimicrob. Agents Chemother. | pmid:4157349 |
| Pestka S et al. | Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes. | 1974 | Antimicrob. Agents Chemother. | pmid:4157350 |
| Blackman Northwood J et al. | Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005. | 2009 | Antimicrob. Agents Chemother. | pmid:19258262 |
| FÃ brega A et al. | Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG. | 2010 | Antimicrob. Agents Chemother. | pmid:20008776 |
| MarÃn M et al. | Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr. | 2015 | Antimicrob. Agents Chemother. | pmid:25385106 |
| Hoppe JE and Bryskier A | In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). | 1998 | Antimicrob. Agents Chemother. | pmid:9559823 |
| Garcia-Bermejo I et al. | Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. | 1998 | Antimicrob. Agents Chemother. | pmid:9559831 |
| Danilchanka O et al. | Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. | 2008 | Antimicrob. Agents Chemother. | pmid:18458127 |
| Cohn JR et al. | In vitro antagonism by erythromycin of the bactericidal action of antimicrobial agents against common respiratory pathogens. | 1980 | Antimicrob. Agents Chemother. | pmid:7235675 |
| Jacobs MR et al. | Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. | 2010 | Antimicrob. Agents Chemother. | pmid:20308374 |
| Bucki R et al. | Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate. | 2010 | Antimicrob. Agents Chemother. | pmid:20308375 |
| Clarebout G et al. | Macrolide resistance gene mreA of Streptococcus agalactiae encodes a flavokinase. | 2001 | Antimicrob. Agents Chemother. | pmid:11451686 |
| Goldstein EJ et al. | In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. | 2001 | Antimicrob. Agents Chemother. | pmid:11451698 |
| Jung YH et al. | Characterization of two newly identified genes, vgaD and vatH, [corrected] conferring resistance to streptogramin A in Enterococcus faecium. | 2010 | Antimicrob. Agents Chemother. | pmid:20713681 |
| Ge Y et al. | In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States. | 2008 | Antimicrob. Agents Chemother. | pmid:18625769 |
| Mu Y et al. | Synergistic effects of anti-CmeA and anti-CmeB peptide nucleic acids on sensitizing Campylobacter jejuni to antibiotics. | 2013 | Antimicrob. Agents Chemother. | pmid:23817373 |
| Benoni G et al. | Pharmacokinetics and human tissue penetration of flurithromycin. | 1988 | Antimicrob. Agents Chemother. | pmid:3245699 |
| Mendes RE et al. | In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United States. | 2016 | Antimicrob. Agents Chemother. | pmid:27161634 |
| Piccinelli G et al. | In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. | 2014 | Antimicrob. Agents Chemother. | pmid:24379197 |
| Naik S and Ruck R | In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. | 1989 | Antimicrob. Agents Chemother. | pmid:2817858 |
| Zarazaga M et al. | In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. | 1999 | Antimicrob. Agents Chemother. | pmid:10582908 |
| Williams MD et al. | Early treatment of Campylobacter jejuni enteritis. | 1989 | Antimicrob. Agents Chemother. | pmid:2818711 |
| Jorgensen JH et al. | Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. | 1991 | Antimicrob. Agents Chemother. | pmid:1834012 |
| Truffot-Pernot C et al. | Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. | 1991 | Antimicrob. Agents Chemother. | pmid:1834015 |
| Berryman DI and Rood JI | Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens. | 1989 | Antimicrob. Agents Chemother. | pmid:2552908 |
| Vildé JL et al. | Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents. | 1986 | Antimicrob. Agents Chemother. | pmid:3492176 |
| Yamane K et al. | New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. | 2007 | Antimicrob. Agents Chemother. | pmid:17548499 |
| Perreten V et al. | Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. | 2001 | Antimicrob. Agents Chemother. | pmid:11257023 |
| Richter SS et al. | Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. | 2011 | Antimicrob. Agents Chemother. | pmid:21709080 |
| Ip M et al. | Macrolide resistance in Streptococcus pneumoniae in Hong Kong. | 2001 | Antimicrob. Agents Chemother. | pmid:11302833 |
| McGee L et al. | Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa. | 2001 | Antimicrob. Agents Chemother. | pmid:11302838 |
| Pestka S et al. | Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes. | 1974 | Antimicrob. Agents Chemother. | pmid:15825314 |
| Pestka S and LeMahieu RA | Inhibition of [14C]chloramphenicol binding to Escherichia coli ribosomes by erythromycin derivatives. | 1974 | Antimicrob. Agents Chemother. | pmid:15828169 |
| Miller LW et al. | Diphtheria carriers and the effect of erythromycin therapy. | 1974 | Antimicrob. Agents Chemother. | pmid:15828187 |
| Rakita RM et al. | Intracellular activity of azithromycin against bacterial enteric pathogens. | 1994 | Antimicrob. Agents Chemother. | pmid:7810998 |
| Pankuch GA et al. | Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. | 1994 | Antimicrob. Agents Chemother. | pmid:7811020 |
| Hansen SL et al. | Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin. | 1981 | Antimicrob. Agents Chemother. | pmid:6812492 |
| Aoshiba K et al. | Erythromycin shortens neutrophil survival by accelerating apoptosis. | 1995 | Antimicrob. Agents Chemother. | pmid:7785987 |
| Brummett RE and Fox KE | Vancomycin- and erythromycin-induced hearing loss in humans. | 1989 | Antimicrob. Agents Chemother. | pmid:2669623 |
| Goldstein EJ and Sutter VL | Effect of carbon dioxide on erythromycin. | 1983 | Antimicrob. Agents Chemother. | pmid:6404220 |
| Le Saux NM et al. | In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi. | 1987 | Antimicrob. Agents Chemother. | pmid:2959199 |
| Zhanel GG et al. | Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. | 2003 | Antimicrob. Agents Chemother. | pmid:12760860 |
| Zhanel GG et al. | Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. | 2003 | Antimicrob. Agents Chemother. | pmid:12760861 |
| Gaudreau C and Gilbert H | Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, Canada. | 2003 | Antimicrob. Agents Chemother. | pmid:12760892 |
| Müller M et al. | Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. | 1996 | Antimicrob. Agents Chemother. | pmid:9124826 |
| Roberts MC et al. | Characterization of tetracycline and erythromycin resistance determinants in Treponema denticola. | 1996 | Antimicrob. Agents Chemother. | pmid:8807063 |
| Roord JJ et al. | Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. | 1996 | Antimicrob. Agents Chemother. | pmid:9124837 |
| Tamaoki J et al. | Effects of roxithromycin and erythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas. | 1996 | Antimicrob. Agents Chemother. | pmid:8807072 |
| Szumowski JD et al. | Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. | 2007 | Antimicrob. Agents Chemother. | pmid:17116664 |
| Teng LJ et al. | High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. | 2001 | Antimicrob. Agents Chemother. | pmid:11709309 |
| de Azavedo JC et al. | Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. | 2001 | Antimicrob. Agents Chemother. | pmid:11709331 |
| Simor AE et al. | Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. | 1989 | Antimicrob. Agents Chemother. | pmid:2712542 |
| Neuhauser MM et al. | Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. | 2001 | Antimicrob. Agents Chemother. | pmid:11709352 |
| Singh KV et al. | In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. | 2001 | Antimicrob. Agents Chemother. | pmid:11709359 |
| Wolff KA et al. | Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria. | 2009 | Antimicrob. Agents Chemother. | pmid:19528288 |